Simplex Infrastructures Raises Rs. 57 Crore through Allotment of 26.3 Lakh Equity Shares on Preferential Basis
Shares allotted at Rs.289 each to promoter and non-promoter investors upon warrant conversion, pending stock exchange listing approvals
Simplex Infrastructures Limited announced the preferential allotment of 26,30,104 equity shares at Rs.289 per share, raising Rs. 57.00 crore from promoter group and non-promoter investors through warrant conversion. The shares carry a face value of Rs.2 each and will rank pari passu with existing shares, pending listing approval.
Simplex Infrastructures Limited
Preferential Issue
Simplex Infrastructures Limited completed the allotment of 26,30,104 equity shares at a price of Rs.289 each on a preferential basis through conversion of warrants, raising Rs. 57,00,75,042 from promoters and non-promoters on November 21, 2026.
The allotted equity shares have a face value of Rs.2 each and carry a premium of Rs.287 per share. They will rank pari passu with the existing equity shares of the company once listed.
The allotment followed receipt of the balance 75% consideration amount as per SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the shares will be listed on stock exchanges subject to necessary approvals.
Four investors participated in this preferential allotment, including promoter group entities and non-promoter investors. Following the allotment, promoter group shareholding is 8.00%.
There remain 39,25,779 warrants eligible for conversion within 18 months from the date of the initial allotment of warrants.
Highlights
- Allotment of 26,30,104 equity shares at Rs.289 per share including Rs.287 premium
- Amount raised totals Rs.57,00,75,042 from warrant conversion
- Shares have a face value of Rs.2 each and rank pari passu with existing shares
- Four investors participated, including promoter group and non-promoters
- 39,25,779 warrants remain convertible within 18 months after allotment
Key Data Snapshot
What happened
- Simplex Infrastructures' Committee of Directors approved allotment of 26,30,104 equity shares on November 21, 2026.
- Shares issued at Rs.289 each (including premium) on preferential basis through conversion of warrants.
- Amount of Rs.57,00,75,042 received as balance 75% consideration from promoter and non-promoter investors.
Transaction details
- The equity shares have a face value of Rs.2 each and rank pari passu with existing shares.
- Allotted shares will be listed on stock exchanges subject to regulatory approvals.
- Four investors participated, including promoter group and non-promoters.
- 39,25,779 warrants remain eligible for conversion within 18 months from the initial allotment date.
Regulatory and governance context
- The allotment complies with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
- Details disclosed under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Highlights
- Allotment of 26,30,104 equity shares at Rs.289 per share including Rs.287 premium
- Amount raised totals Rs.57,00,75,042 from warrant conversion
- Shares have a face value of Rs.2 each and rank pari passu with existing shares
- Four investors participated, including promoter group and non-promoters
- 39,25,779 warrants remain convertible within 18 months after allotment
Disclosures
- SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Promoter group participated, holding 8.00% post-allotment.
More News on Preferential Issue
View allLatest corporate announcements and market updates in Preferential Issue.
Jubilant Pharmova Receives Shareholder Approval for Private Placement of Non-Convertible Debentures
Jubilant Pharmova Limited has obtained shareholder approval through a postal ballot conducted on November 20, 2026, for the issuance of Non-Convertible Debentures on a private placement basis, allowing the company to raise debt capital.
Read Full StoryIndian Bank Approves Rs. 3000 Crore Additional Capital Raise via Basel III AT1/Tier 2 Bonds for FY 2026-27
Indian Bank's Board of Directors approved raising an additional Rs. 3000 crore through Basel III compliant Additional Tier 1 (AT1) or Tier 2 Bonds, increasing its total capital raising approval to Rs. 5000 crore for the financial year 2026-27.
Read Full StoryZelio E-Mobility Approved by BSE for Rs. 16.5 Crore Preferential Equity and Convertible Warrant Issue
Zelio E-Mobility Limited has obtained in-principle approval from BSE to issue 9,73,000 equity shares and 9,96,000 convertible warrants in a preferential allotment at a price of Rs. 853 per share or warrant, targeting both non-promoter and promoter investors.
Read Full Story